Jeffrey V Lazarus

4

Articles

0

Comments
La donne a changé et le déploiement mondial, même réussi, des vaccins actuels ne garantit plus la victoire. Daniel Cole/AP

Les vaccins ne suffiront pas contre les variants. Il faut une stratégie mondiale de « suppression maximale » du virus

Susan Michie, UCL; Chris Bullen, University of Auckland, Waipapa Taumata Rau; Jeffrey V Lazarus, Barcelona Institute for Global Health (ISGlobal); John N. Lavis, McMaster University; John Thwaites, Monash University; Liam Smith, Monash University; Salim Abdool Karim, Centre for the AIDS Program of Research in South Africa (CAPRISA), and Yanis Ben Amor, Columbia University

Les variants ont changé la donne. Nous devons agir en conséquence pour éviter de nouvelles vagues d’infections, de nouvelles fermetures, restrictions, hospitalisations et décès évitables.
Daniel Cole/AP

New COVID variants have changed the game, and vaccines will not be enough. We need global ‘maximum suppression’

Susan Michie, UCL; Chris Bullen, University of Auckland, Waipapa Taumata Rau; Jeffrey V Lazarus, Barcelona Institute for Global Health (ISGlobal); John N. Lavis, McMaster University; John Thwaites, Monash University; Liam Smith, Monash University; Salim Abdool Karim, Centre for the AIDS Program of Research in South Africa (CAPRISA), and Yanis Ben Amor, Columbia University

COVID-19 variants of concern have changed the game. We need to recognise and act on this to avoid future waves of infections, yet more lockdowns and restrictions, and avoidable illness and death.
Manifestantes antimascarillas, antivacunas y antitest de covid en Londres en agosto de 2020. Shutterstock / T Salci

El escepticismo ante las vacunas: un reto en la era de la covid‑19

Jeffrey V Lazarus, Barcelona Institute for Global Health (ISGlobal); Camila Picchio, Barcelona Institute for Global Health (ISGlobal); Cristina Rius i Gibert, l'Agència de Salut Pública de Barcelona, and Scott C. Ratzan, CUNY Graduate Center

Se espera que en un tiempo récord se desarrolle una vacuna contra la covid-19 segura y eficaz, cuya aprobación podría producirse en algún momento de 2021.
The increasingly well-coordinated global anti-vaccine movement has repurposed itself to challenge the very reality of COVID-19. Hasan Esen/Anadolu Agency via Getty Images

COVID‑19: A global survey shows worrying signs of vaccine hesitancy

Scott C. Ratzan, CUNY Graduate Center; Agnes Binagwaho, University of Global Health Equity; Heidi Larson, London School of Hygiene & Tropical Medicine; Jeffrey V Lazarus, Barcelona Institute for Global Health (ISGlobal); Kenneth Rabin, CUNY Graduate Center, and Lawrence O. Gostin, Georgetown University

A safe, effective COVID-19 vaccine is expected to be developed in record time and may be approved for production, distribution and acceptance some time in 2021.

Contact Jeffrey for

  • General
  • Media request
  • Speaking request
  • Consulting / Advising
  • Research collaboration
  • Research supervision